Remifemin Preventing the Climacteric Symptoms in Breast Cancer
NCT03339882
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
85
Enrollment
OTHER
Sponsor class
Conditions
Effect of Drugs
Safety Issues
Interventions
DRUG:
Remifemin
Sponsor
Zhejiang Cancer Hospital